124 related articles for article (PubMed ID: 1384525)
21. Immunohistochemically visualized localisation of gangliosides Glac2 (GD3) and Gtri2 (GD2) in cells of human intracranial tumors.
Mennel HD; Bosslet K; Geissel H; Bauer BL
Exp Toxicol Pathol; 2000 Aug; 52(4):277-85. PubMed ID: 10987178
[TBL] [Abstract][Full Text] [Related]
22. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
Tai T; Kawashima I; Tada N; Dairiki K
J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507
[TBL] [Abstract][Full Text] [Related]
23. Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody.
Nilsson O; Månsson JE; Lindholm L; Holmgren J; Svennerholm L
FEBS Lett; 1985 Mar; 182(2):398-402. PubMed ID: 2984045
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor expression in human gliomas.
Torp SH; Helseth E; Dalen A; Unsgaard G
Cancer Immunol Immunother; 1991; 33(1):61-4. PubMed ID: 2021959
[TBL] [Abstract][Full Text] [Related]
25. Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens.
Vick WW; Tello JW; Wikstrand CJ; He X; Longee D; Fredman P; Svennerholm L; Bigner DD; Johnston WW; Bigner SH
Acta Cytol; 1992; 36(5):697-705. PubMed ID: 1523927
[TBL] [Abstract][Full Text] [Related]
26. Chemical, metabolic and immunological characterization of gangliosides of human glioma cells.
Maeda Y; Yamaki T; Yoshikawa J; Tatewaki K; Piao H; Yu H; Ibayashi Y; Hashi K
Cancer Biochem Biophys; 1998 Nov; 16(4):313-32. PubMed ID: 9925280
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.
Hedberg KM; Dellheden B; Wikstrand CJ; Fredman P
Glycoconj J; 2000 Oct; 17(10):717-26. PubMed ID: 11425192
[TBL] [Abstract][Full Text] [Related]
28. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.
Kotani M; Ozawa H; Kawashima I; Ando S; Tai T
Biochim Biophys Acta; 1992 Jul; 1117(1):97-103. PubMed ID: 1627599
[TBL] [Abstract][Full Text] [Related]
29. Expression of GD2-epitopes in human intracranial tumors and normal brain.
Mennel HD; Bosslet K; Wiegandt H; Sedlacek HH; Bauer BL; Rodden AF
Exp Toxicol Pathol; 1992 Oct; 44(6):317-24. PubMed ID: 1280497
[TBL] [Abstract][Full Text] [Related]
30. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM
Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591
[TBL] [Abstract][Full Text] [Related]
31. Tumor antigens in astrocytic gliomas.
Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
[TBL] [Abstract][Full Text] [Related]
32. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
33. Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions.
Nakamura K; Tanaka Y; Shitara K; Hanai N
Cancer Immunol Immunother; 2001 Jul; 50(5):275-84. PubMed ID: 11499811
[TBL] [Abstract][Full Text] [Related]
34. Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients.
Tai T; Cahan LD; Paulson JC; Saxton RE; Irie RF
J Natl Cancer Inst; 1984 Sep; 73(3):627-33. PubMed ID: 6206271
[TBL] [Abstract][Full Text] [Related]
35. Expression of gangliosides GD3 and 3'-isoLM1 in autopsy brains from patients with malignant tumors.
Fredman P; von Holst H; Collins VP; Dellheden B; Svennerholm L
J Neurochem; 1993 Jan; 60(1):99-105. PubMed ID: 8417168
[TBL] [Abstract][Full Text] [Related]
36. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
37. Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
Takasu S; Takahashi T; Okamoto S; Oriuchi N; Nakayashiki N; Okamoto K; Muramatsu H; Hayashi T; Nakahara N; Mizuno M; Wakabayashi T; Higuchi T; Endo K; Kozaki K; Miyaishi O; Saga S; Ueda R; Yoshida J; Yoshikawa K
J Neurooncol; 2003 Jul; 63(3):247-56. PubMed ID: 12892230
[TBL] [Abstract][Full Text] [Related]
38. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
39. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies in neuro-oncology.
Stavrou D
Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
